Skip to main content

Ultomiris Prices, Coupons and Patient Assistance Programs

Ultomiris (ravulizumab) is a member of the selective immunosuppressants drug class and is commonly used for Hemolytic Uremic Syndrome, Myasthenia Gravis, and Paroxysmal Nocturnal Hemoglobinuria.

The cost for Ultomiris intravenous solution (100 mg/mL) is around $6,753 for a supply of 3 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Ultomiris prices

Intravenous Solution

Quantity Per unit Price
3 milliliters $2,250.97 $6,752.91
11 milliliters $2,248.67 $24,735.34

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Ultomiris Coupons, Copay Cards and Rebates

Ultomiris offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Ultomiris Alexion OneSource CoPay Program

Eligible commercially insured patients may pay as little as $0 for out-of-pocket costs up to a maximum savings of $15,000 per calendar year; for additional information contact the program at 888-765-4747.

Applies to:
Number of uses:
per prescription per calendar year

Form more information phone: 888-765-4747 or Visit website

Patient Assistance & Copay Programs for Ultomiris

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Ultomiris (ravulizumab-cwvz) Injection; IV

More information please phone: 866-316-7263 Visit Website

Provider: OneSource Patient Support Program from Alexion

Eligibility requirements:
  1. Determined case by case
  2. Determined case by case
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Insurance benefits, claims assistance, or other reimbursement help is offered. Health care providers must enroll in the REMS program prior to submitting the Patient Assistance Program Application Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Ultomiris (ravulizumab-cwvz) Injection; IV

More information please phone: 888-765-4747 Visit Website